scorecardresearch
Thursday, August 14, 2025
TopicPfizer

Topic: Pfizer

Why the above-90% effective Moderna and Pfizer vaccines are truly a breakthrough

The most important challenge for development of an mRNA vaccine remains its inherent instability.

Pfizer Covid vaccine faces hurdles after USFDA filing

Shown to be 95% effective and without any major safety issues, their vaccine could be the first to be cleared for use, but first it must undergo a thorough vetting.

There’s light at the end of the Covid tunnel — the glimmer of a vaccine needle

With Pfizer, Moderna as well as developers of Sputnik V and CoronaVac citing over 90% efficacy of their vaccines, the world finally has a reason to hope 2021 will be different.

Tracking side effects will be the next big challenge for Pfizer, Moderna Covid vaccines

The side-effect reports of the vaccine have the potential to be a gold mine for anti-vaxxers as vaccine skepticism grows around the world.

Pfizer Covid vaccine reaches key safety milestone, to seek emergency US FDA approval

Pfizer CEO Albert Bourla says important questions about the vaccine still remain to be answered, including how durable the protection could be.

Moderna’s Covid vaccine offers antidote to Pfizer’s deep-freeze problem

While Pfizer's vaccine has to be kept in -70 degree and can only last up to 5 days, Moderna's vaccine can last up to 30 days in regular freezers.

Modi govt eyes pvt sector vaccinators for Covid as India has only 70,000 in public sector

These vaccinators run Universal Immunisation Programme that inoculates mothers & children, and govt is concerned about diverting resources for Covid vaccine.

India’s mRNA-based Covid vaccine won’t need ultra cold conditions for storage — Pune firm

Gennova Biopharmaceuticals CEO Sanjay Singh tells ThePrint their vaccine could be stored at around 2 to 8 degrees Celsius, and the trial is likely to be completed by March.

Pfizer vaccine success opens hot stock-market trade

Given the bets the market has seen in the different pandemic phases — from ventilator makers to medical gloves suppliers — it’s no surprise this new phase is attracting attention.

Temperature challenge can make Pfizer Covid vaccine a shot for the rich

The investment and coordination required to build deep-freeze production, storage & transportation networks for the vaccine will ensure that only rich nations are guaranteed access.

On Camera

Asim Munir wants to be guardian of the Middle East. He’s fated to fail at home

Countering insurgency needs the Pakistan Army to demonstrate a political will that ties leaders at the centre with those in the borderlands. But it may not have the imagination.

Slashing GST on waste can unlock Rs 1.8 lakh crore, high tax hurting circular economy goals—CSE

Centre for Science and Environment in new report makes case for rationalising GST on waste material, saying most informal operators can’t afford high tax & it also hinders recycling.

India, US troops to undertake joint military exercise next month, first after Op Sindoor

21st edition of annual joint military exercise will be held from 1 to 16 September, aimed at sharing military tech, operational best practices & disaster relief coordination methods.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.